What You Should Know

An AI-generated overview of this parcel — zoning context, recent activity, and what matters most for redevelopment.

Zoning & Land Use

Zoning DistrictI2 - Medium Industrial

Building TypeHEALTH FAC MED CENT MAS+O

CategoryCOMMERCIAL

Year Built2009

Valuation & Sales

Market Value (TY2027)$633,700

Last Sale Price$1,368,000

Last Sale DateJune 30, 2025

Taxable Land$0

Taxable Building$0

Homestead ExemptionNone

Physical Characteristics

Total Lot Area109,861 sq ft

Livable Area2,700 sq ft

Frontage298 ft

Depth514 ft

StoriesN/A

UnitsN/A

BedroomsN/A

BathroomsN/A

Exterior ConditionAverage

GarageN/A

Ownership

OwnerSelah Development II Llc

Political Representation

City Council DistrictN/A

City Council MemberN/A

Ward35

PA House DistrictN/A

PA House RepresentativeN/A

PA Senate DistrictN/A

PA Senate RepresentativeN/A

Congressional DistrictN/A

Congressional RepresentativeN/A

Census Tract291

Activity Timeline

Nearby Activity

Comparable Sales

Two different questions, answered together: what this property is worth as built, and what the land underneath it is worth on its own. Not an appraisal.

Building value

Arm's-length sales of similar nearby homes — prices the structure.

Land value

Vacant-land and teardown sales — prices the lot on its own.

Sale-by-sale detail

Buildable CapacityBeta

Limited data — special district

I2Industrial

Zoning Envelope

Max Height: No limit
Lot Coverage: —
FAR: —

By-right capacity based on Philadelphia Zoning Code §14-701. Actual development potential may vary based on overlays, variances, setbacks, parking requirements, and site conditions.Utilization and redevelopment potential data will be available after the next data update.

3D Massing

Development Pro FormaBeta

Pro forma analysis is not available for single-family parcels without computed gross floor area.

LIHTC Screening Beta

LIHTC screening requires by-right residential development capacity. This parcel's zoning (I2) yields no residential units, so credit feasibility doesn't apply.